Comparison Between Standard Deep Anterior Lamellar Keratoplasty (S-DALK) and Intralase Enabled Deep Anterior Lamellar Keratoplaty (IE-DALK)

Keratoconus Clinical Trial

Official title:

Comparison Between Standard Deep Anterior Lamellar Keratoplasty (S-DALK) and Intralase Enabled Deep Anterior Lamellar Keratoplaty (IE-DALK)

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT03732599
• Other study ID #: 30457
• Status: Enrolling by invitation
• Phase: N/A
• Start date: April 8, 2015
• Est. completion date: May 31, 2021

Study information

• Verified date: November 2018
• Source: University of Toronto
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A prospective comparison between standard deep anterior lamellar keratoplasty (S-DALK) performed manually using a blade (trephine) and femtosecond laser-enabled deep anterior lamellar keratoplasty (IE DALK), where incisions are performed using the femtosecond laser.

Description:

Even though corneal transplants have been around for more than 100 years, and tools to improve their surgical technique keep getting perfected, both regular and irregular postoperative astigmatism continue to be major concerns in achieving predictable visual results. Femtosecond laser technology allows for the creation of more precise incisions with more reproducible patterns, which could lead us to believe that astigmatism management and visual results should be improved with this technology. This would be the first study to prospectively analyze standard versus femtosecond laser-enabled deep anterior lamellar keratoplasties in order to elucidate their relative advantages in the quest for a gold standard.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 100
• Est. completion date: May 31, 2021
• Est. primary completion date: December 31, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 70 Years

Eligibility

Inclusion Criteria:

• Age between 18 and 70 years

• Either advanced keratoconus or corneal scarring requiring a deep anterior lamellar keratoplasty

Exclusion Criteria:

• Previous keratoplasty

• Advanced glaucoma

• Any other retinal or optic nerve pathology that could potentially affect visual outcome

• Strabismus or amblyopia

• Significant limbal stem cell deficiency (invlolving > 3 limbal clock hours)

• Active autoimmune disease.

Related Conditions & MeSH terms

• DALK Corneal Transplant
• Keratoconus
• Scar

Intervention

Procedure:
• Standard Deep Anterior Keratoplasty (S-DALK)
Standard (with the use of a blade) deep anterior lamellar keratoplasty (DALK), which is a partial thickness corneal transplant, which has been shown to be a safe and effective procedure.
• IE-DALK (femtosecond)
Femtosecond deep anterior lamellar keratoplasty (DALK). The femotosecond laser technology allows for the creation of precise and reproducible corneal incisions.

Locations

Country	Name	City	State
n/a

Sponsors (6)

Lead Sponsor	Collaborator
University of Toronto	Applied Health Research Centre, Kensington Eye Institute, St. Michael's Hospital, Toronto, Sunnybrook Health Sciences Centre, University Health Network, Toronto

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from preoperative topographical corneal astigmatism	Corneal astigmatism is the difference (expressed in Diopter units) of refractive power between the steep and flat corneal meridians and is measured using corneal topography. Values range between 0 and 20 diopters. Lower values represent a better outcome.	preoperatively, 6, 12 and 15 months postoperatively
Secondary	Change from preoperative best-corrected distance visual acuity (BCVA)	BCVA will be measured using an ETDRS acuity chart and recorded in logMAR (logarithm of the minimal angle of resolution) units. Value range is between -0.125 and 3 logMAR. Lower values represent a better outcome.	preoperatively, 6, 12 and 15 months postoperatively.
Secondary	Change from preoperative uncorrected distance visual acuity (UCVA)	UCVA will be measured using an ETDRS acuity chart and recorded in logMAR (logarithm of the minimal angle of resolution) units. Value range is between -0.125 and 3 logMAR. Lower values represent a better outcome.	preoperatively, 6, 12 and 15 months postoperatively.
Secondary	Big-bubble success rate	This outcome represents the number of procedures where the deep anterior lamellar keratoplasty (DALK) procedure was completed using the "big bubble" surgical technique. This can either be "Yes" for successful or "No" for unsuccessful completion of this technique. Higher big-bubble success rates represent a better outcome.	6 months postoperatively.
Secondary	Rate of conversion to penetrating keratoplasty	This outcome represents the number of failed DALK procedures (using any of the possible DALK techniques) that needed to be converted to a procedure other than DALK (a penetrating keratoplasty procedure). This can either be "Yes" for DALK failure and conversion to penetrating keratoplasty or "No" for a successful DALK procedure. Higher penetrating keratoplasty conversion rates represent a worse outcome.	6 months postoperatively.
Secondary	Change from preoperative endothelial cell count	This is the density of corneal endothelial cells (measured as cells per square millimeter). Value range is between 300 and 3500 cells/square millimeter. Higher values represent a better outcome.	preoperatively, 6, 12 and 15 months postoperatively.
Secondary	Change from preoperative pachymetry	This represents corneal thickness, measured in microns. Value ranges are between 200 and 800 microns. Values between 500 and 600 micron represents a good outcome.	preoperatively, 6, 12 and 15 months postoperatively.
Secondary	Change from preoperative higher-order optical aberrations	Values of total higher-order optical aberrations and coma higher-order optical aberration measured in RMS (root mean square) units. Value range is between -20 and +20 RMS. Lower absolute value represents a better outcome (values closer to zero on both the negative and positive ends).	preoperatively, 6, 12 and 15 months postoperatively.